Trademark: 88614061
Word
DIRECTMX
Status
Registered
Status Code
700
Status Date
Tuesday, December 1, 2020
Serial Number
88614061
Registration Number
6208690
Registration Date
Tuesday, December 1, 2020
Mark Type
4000
Filing Date
Thursday, September 12, 2019
Published for Opposition
Tuesday, September 15, 2020

Trademark Owner History
SALIPRO BIOTECH AB - Original Registrant

Classifications
1 Biological preparations for use in industry; Biological preparations for use in science; Carriers for biologically active compounds; Biological substances, materials, preparations and elements for scientific and industrial use in vivo and in vitro; Chemical substances, chemical materials and chemical preparations, and natural elements for scientific and industrial use in vivo and in vitro; biological materials for use in industry and science; Chemical substances, materials, preparations and elements for cosmetic preparations; Biological substances, materials, preparations and elements for cosmetic preparations; Lipid nanoparticles for use in industry and science; Lipid nanoparticles comprising protein for use in industry and science; Saposin-lipid nanoparticles for use in industry and science
5 Biochemical preparations for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases; Biochemical preparations for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases in non-human animals; Biological reagents for medical use; Biological reagents for veterinary use; Carriers for pharmaceutical, medical, veterinary or diagnostic compounds; Biochemical preparations for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases in humans and non-human animals and for use in a diagnostic method; Medicinal preparations and substances for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases in humans and non-human animals; Veterinary vaccines; Human vaccine preparations; Lipid nanoparticles for medicinal, diagnostic or pharmaceutical purposes; Lipid nanoparticles comprising protein for medical, diagnostic or pharmaceutical purposes; Saposin-lipid nanoparticles for medical, diagnostic or pharmaceutical purposes
40 Treatment of cells and/or viruses and/or biological membranes to obtain carriers for biologically active, pharmaceutical or diagnostic compounds; Conversion of cells and/or viruses and/or biological membranes into biochemical preparations; Custom manufacturing of lipid nanoparticles in particular of lipid nanoparticles comprising protein or Saposin-lipid nanoparticles; Processing of cells and/or viruses and/or biological membranes for third parties
42 Biological laboratory services; Biochemistry consultancy; Consulting services in the field of lipid nanoparticles in particular in the field of lipid nanoparticles comprising protein or Saposin-lipid nanoparticles
DIRECT MX

Trademark Events
Dec 1, 2020
Registered-Principal Register
Sep 15, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 15, 2020
Published For Opposition
Aug 26, 2020
Notification Of Notice Of Publication E-Mailed
Aug 9, 2020
Approved For Pub - Principal Register
Aug 9, 2020
Examiner's Amendment Entered
Aug 9, 2020
Notification Of Examiners Amendment E-Mailed
Aug 9, 2020
Examiners Amendment E-Mailed
Aug 9, 2020
Examiners Amendment -Written
Jun 24, 2020
Notification Of Letter Of Suspension E-Mailed
Jun 24, 2020
Letter Of Suspension E-Mailed
Jun 24, 2020
Suspension Letter Written
Jun 15, 2020
Teas/Email Correspondence Entered
Jun 15, 2020
Correspondence Received In Law Office
Jun 15, 2020
Assigned To Lie
Jun 4, 2020
Teas Response To Office Action Received
Dec 19, 2019
Notification Of Non-Final Action E-Mailed
Dec 19, 2019
Non-Final Action E-Mailed
Dec 19, 2019
Non-Final Action Written
Dec 13, 2019
Assigned To Examiner
Sep 20, 2019
New Application Office Supplied Data Entered In Tram
Sep 16, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24